Order Article Reprints

Zaabalawi A, Renshall L, Beards F, Lightfoot AP, Degens H, Alexander Y, Hasan R, Bilal H, Graf BA, Harris LK, et al. Internal Mammary Arteries as a Model to Demonstrate Restoration of the Impaired Vasodilation in Hypertension, Using Liposomal Delivery of the CYP1B1 Inhibitor, 2,3′,4,5′-Tetramethoxystilbene. Pharmaceutics. 2022; 14(10):2046. https://doi.org/10.3390/pharmaceutics14102046

Zaabalawi, Azziza, Lewis Renshall, Frances Beards, Adam P. Lightfoot, Hans Degens, Yvonne Alexander, Ragheb Hasan, Haris Bilal, Brigitte A. Graf, Lynda K. Harris, and et al. 2022. "Internal Mammary Arteries as a Model to Demonstrate Restoration of the Impaired Vasodilation in Hypertension, Using Liposomal Delivery of the CYP1B1 Inhibitor, 2,3′,4,5′-Tetramethoxystilbene" Pharmaceutics 14, no. 10: 2046. https://doi.org/10.3390/pharmaceutics14102046

Zaabalawi, A., Renshall, L., Beards, F., Lightfoot, A. P., Degens, H., Alexander, Y., Hasan, R., Bilal, H., Graf, B. A., Harris, L. K., & Azzawi, M. (2022). Internal Mammary Arteries as a Model to Demonstrate Restoration of the Impaired Vasodilation in Hypertension, Using Liposomal Delivery of the CYP1B1 Inhibitor, 2,3′,4,5′-Tetramethoxystilbene. Pharmaceutics, 14(10), 2046. https://doi.org/10.3390/pharmaceutics14102046